Stay updated on SB12 vs Soliris in PNH Clinical Trial
Sign up to get notified when there's something new on the SB12 vs Soliris in PNH Clinical Trial page.

Latest updates to the SB12 vs Soliris in PNH Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly details regarding a Phase III study comparing SB12 and Soliris® for treating Paroxysmal Nocturnal Hemoglobinuria, including inclusion and exclusion criteria for participants. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference14%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to SB12 vs Soliris in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB12 vs Soliris in PNH Clinical Trial page.